Skip to main content

Mizell Steven's Form 4 filing

Merck & Co., Inc. (MRK) · filed Feb 2, 2024

Accession no.
0001127602-24-003099
Filed
Feb 2, 2024
Trade date
Feb 2, 2024
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.42M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mizell StevenCIK 0001189403Officer (EVP, Chief HR Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseAcquired+824$70.71+$58,265.0442,143.15Direct
Feb 2, 2024Common StockMOption exerciseAcquired+32,170$73.73+$2,371,894.174,313.15Direct
Feb 2, 2024Common StockSSaleDisposed−50,694$126.65−$6,420,395.123,619.15Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 2, 2024Common StockMOption exerciseDisposed−824$0.00$00Direct
Feb 2, 2024Common StockMOption exerciseDisposed−32,170$0.00$022,088Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)